PHGE
PHGE
AMEX · Biotechnology

Biomx Inc

$3.93
-0.63 (-13.82%)
As of Feb 8, 2:31 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +437.7% upside
Low Target $13.63
Average Target $21.13
High Target $23.51
Current Price $3.93
Current
$3.93
Target
$21.13
$13.63 $21.13 avg $23.51
Scenario Analysis
Bear Case
$13.63
246.8%
Low target
Base Case
$21.13
+437.7%
Avg target
Bull Case
$23.51
+498.2%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$19.15
-79.5% from high
52-Week Low
$8.60
+-54.3% from low
Target vs 52W High
$21.13
+10.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%